Jacobs Levy Equity Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.83M Sell
148,240
-52,289
-26% -$1.35M 0.02% 501
2025
Q1
$2.05M Buy
200,529
+25,398
+15% +$259K 0.01% 656
2024
Q4
$2.44M Sell
175,131
-11,083
-6% -$155K 0.01% 559
2024
Q3
$3.63M Sell
186,214
-5,332
-3% -$104K 0.01% 499
2024
Q2
$3.56M Buy
191,546
+64,134
+50% +$1.19M 0.01% 500
2024
Q1
$1.79M Sell
127,412
-99,532
-44% -$1.39M 0.01% 617
2023
Q4
$1.92M Sell
226,944
-100,039
-31% -$848K 0.01% 609
2023
Q3
$2.92M Buy
326,983
+2,284
+0.7% +$20.4K 0.02% 491
2023
Q2
$2.8M Buy
324,699
+150,160
+86% +$1.3M 0.02% 507
2023
Q1
$1.84M Buy
174,539
+3,149
+2% +$33.2K 0.01% 589
2022
Q4
$5.81M Buy
171,390
+102,195
+148% +$3.46M 0.04% 366
2022
Q3
$3.32M Buy
69,195
+53,997
+355% +$2.59M 0.03% 467
2022
Q2
$866K Buy
+15,198
New +$866K 0.01% 781
2022
Q1
Sell
-6,194
Closed -$1.26M 1049
2021
Q4
$1.26M Buy
6,194
+389
+7% +$78.8K 0.01% 705
2021
Q3
$1.56M Buy
5,805
+4,106
+242% +$1.11M 0.01% 664
2021
Q2
$437K Buy
1,699
+392
+30% +$101K ﹤0.01% 889
2021
Q1
$392K Sell
1,307
-3,725
-74% -$1.12M ﹤0.01% 897
2020
Q4
$1.28M Sell
5,032
-87
-2% -$22.2K 0.01% 664
2020
Q3
$1.27M Buy
5,119
+1,217
+31% +$303K 0.01% 609
2020
Q2
$1.36M Buy
+3,902
New +$1.36M 0.01% 604
2016
Q2
Sell
-792
Closed -$163K 1203
2016
Q1
$163K Buy
+792
New +$163K ﹤0.01% 995
2015
Q3
Sell
-18,583
Closed -$3.49M 852
2015
Q2
$3.49M Buy
18,583
+11,466
+161% +$2.15M 0.07% 276
2015
Q1
$1.17M Sell
7,117
-25,509
-78% -$4.21M 0.02% 447
2014
Q4
$7.59M Buy
32,626
+8,507
+35% +$1.98M 0.13% 200
2014
Q3
$4.37M Buy
24,119
+4,560
+23% +$826K 0.07% 260
2014
Q2
$3.76M Buy
+19,559
New +$3.76M 0.06% 310
2014
Q1
Sell
-5,614
Closed -$956K 974
2013
Q4
$956K Sell
5,614
-1,278
-19% -$218K 0.01% 583
2013
Q3
$1.08M Buy
+6,892
New +$1.08M 0.02% 517